CClinicalTrials.gg
CompletedNCT06286982Updated Aug 11, 2025

The Oral Symptom Assessment Scale in Older Patients With Frailty

An observational study in Frailty and Older Adults, sponsored by Our Lady's Hospice and Care Services. Completed at 2 sites in Ireland. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2025-08-11.

Sponsored by Our Lady's Hospice and Care Services · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
250
Ages
65 Years and older
Sex
All
01

Study summary

Oral (or mouth) symptoms are common in older patients who live with frailty. It is known that frailty describes someone's overall resilience and how this relates to the chances of recovery following a health problem. A questionnaire called the Oral Symptom Assessment Scale (or OSAS) was designed to look at mouth symptoms in patients who had an advanced cancer. These symptoms may overlap with patients who have frailty.

This research study is taking place to find out if the OSAS will be a suitable questionnaire that can be used in older patients with frailty.

This study will take place in Our Lady's Hospice \& Care Services, Harold's Cross and St James' Hospital over six months.

Read the detailed description

Participants will be asked by one of our researchers about the presence or absence of 21 mouth symptoms in the last week. If present, the participant will be asked about how bothersome each symptom is as well as the severity and frequency. Up to three additional mouth symptoms that are not listed in the OSAS can be reported and rated in the same way by the participant. Participants will be asked about the questionnaire itself to provide feedback. This will take approximately 10-15 minutes to complete both.

02

Conditions studied

  • Frailty
  • Older Adults

Browse trials for

Keywords

  • Frailty
  • Mouth
  • Symptom assessment
  • Aged
03

In context

Frailty

1,199 studies on the registry are indexed under Frailty; 430 are open to participants now.

This study's enrollment of 250 is above the median of 223 across 496 observational studies indexed under Frailty.

Browse Frailty studies →

Lead sponsor

Our Lady's Hospice and Care Services is the lead sponsor of 8 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Participants will be patients aged 65 years and older with a Clinical Frailty Score (CFS) ≥5 (as determined by the multi-disciplinary clinical team).

Inclusion criteria

  • Age ≥ 65 years old
  • Clinical Frailty Score ≥ 5
  • No known history of dementia
  • The attending clinician should have no concerns about a participant's capacity to consent for this research

Exclusion criteria

Exclusion Criteria:

  • Inability to provide informed consent
  • Inability to complete the questionnaire
  • Abbreviated Mental Test Score -4 (AMT4) \<4
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
250 participants (actual)
Patient registry
No

Groups and cohorts

  • People aged 65 years and older with a Clinical Frailty Score (CFS) ≥5

    The Oral Symptom Assessment Scale will be administered to participants. A feedback questionnaire will also be administered.

    Other: Oral Symptom Assessment Scale

Interventions

  • OtherOral Symptom Assessment Scale

    The Oral Symptom Assessment Scale is a patient-rated oral (or mouth) symptom assessment tool

06

What researchers measure

Primary outcomes

  1. To determine the prevalence of oral symptoms in older patients with frailty

    This will be determined by participants indicating the presence ( or absence) of any one of twenty-one oral symptoms on the oral symptom assessment scale.(OSAS).

    Time frame: In the previous 1 week

  2. To determine the clinical features of these oral symptoms in this group (i.e. frequency, severity and level of distress)

    If a participant indicates the presence of an oral symptom, they are asked to rate the frequency (rated : rarely (1), occasionally (2), frequently (3), almost constantly) (4), severity (rated: slight (1), moderate (2), severe (3), very severe (4)) and level of distress (rated: not at all (0.8), a little bit (1.6), somewhat (2.4), quite a bit (3.2), very much (4)) caused by each symptom. The higher the rating, the higher the frequency, severity or distress.

    Time frame: In the previous 1 week

  3. To determine the relationship between oral symptoms and Clinical Frailty Score / Cumulative Illness Rating Scale for Geriatrics/Medications

    The Clinical Frailty Score (CFS) is a clinician-rated single-item written and visual chart with nine graded illustrations. The baseline of the participant in the two weeks prior to presentation should form the basis of the score as opposed to the current, immediate presentation findings. The frailty cut-off point is ≥ 5. It involves the evaluation of domains including cognition, function, and co-morbidity to produce the score. The Cumulative Illness Rating Scale for Geriatrics (CIR-G)is a scale designed to rate both the presence and severity of a disease in older persons. It encompasses information about both the long-term course and as well as current severity of a disease. It is acquired from patient medical records, interviews with patients as well as contemporaneous examination and test findings. A medication list (both regular and as needed medications) will be recorded.

    Time frame: In the previous 1 week

  4. To provide initial validation of OSAS in older patients with frailty

    OSAS refers to the Oral Symptom Assessment Scale - this a twenty item patient-rated oral symptom assessment instrument which was designed and has been validated in patients with advanced cancer. The symptom of 'drooling' will be added based on investigator experience. The rating system has been outlined above.

    Time frame: In the previous 1 week

07

Study locations

2 sites
  • St James's Hospital
    Dublin, Dublin D8, Ireland
  • Our Lady's Hospice and Care Services
    Dublin, Dublin Dublin 6W, Ireland
08

References and documents

Publications

  • Lindroos EK, Saarela RKT, Suominen MH, Muurinen S, Soini H, Kautiainen H, Pitkala KH. Burden of Oral Symptoms and Its Associations With Nutrition, Well-Being, and Survival Among Nursing Home Residents. J Am Med Dir Assoc. 2019 May;20(5):537-543. doi: 10.1016/j.jamda.2018.10.025. Epub 2018 Dec 9. PubMed 30541688 ↗
  • Saarela RKT, Savikko NM, Soini H, Muurinen S, Suominen MH, Kautiainen H, Pitkala KH. Burden of Oral Symptoms and Health-Related Quality of Life in Long-Term Care Settings in Helsinki, Finland. J Nutr Health Aging. 2019;23(10):1021-1025. doi: 10.1007/s12603-019-1268-9. PubMed 31781733 ↗
  • Miller MD, Paradis CF, Houck PR, Mazumdar S, Stack JA, Rifai AH, Mulsant B, Reynolds CF 3rd. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res. 1992 Mar;41(3):237-48. doi: 10.1016/0165-1781(92)90005-n. PubMed 1594710 ↗
  • Locke T, Keat S, Tate M, Bown A, Hart A, Ghosh R. Assessing the performance of the four question abbreviated mental test in the acute geriatric setting. Acute Med. 2013;12(1):13-7. PubMed 23539371 ↗
  • Davies A, Buchanan A, Todd J, Gregory A, Batsari KM. Oral symptoms in patients with advanced cancer: an observational study using a novel oral symptom assessment scale. Support Care Cancer. 2021 Aug;29(8):4357-4364. doi: 10.1007/s00520-020-05903-1. Epub 2021 Jan 8. PubMed 33416995 ↗
  • Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004 Mar;59(3):255-63. doi: 10.1093/gerona/59.3.m255. PubMed 15031310 ↗

Individual participant data

Plan to share: No — The approved study protocol excludes the sharing of individual participant data with other researchers

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06286982
Lead sponsor
Our Lady's Hospice and Care Services
Responsible party
Prof Andrew Davies (Professor, Our Lady's Hospice and Care Services) — Principal investigator
First posted
Feb 29, 2024
Start date
Jun 6, 2023
Primary completion
Jul 4, 2025
Completion
Jul 4, 2025
Last update
Aug 11, 2025

Study contacts

Davies Andrew, MB MD FRCP
principal investigator · Academic Department of Palliative Medicine, Our Lady's Hospice and Care Services, Dublin

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion